Novo Nordisk stock slides Monday on second-generation GLP-1 data
Novo Nordisk stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP ...
AOL13d
Novo Nordisk stock slides Monday on second-generation GLP-1 data
Novo Nordisk (NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP-1 drug, CagriSema. The drug, a mix of cagrilintide and ...
Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo stock slides 4%
The news sent Roche's stock up more than 4% in trading Wednesday, and Zealand's stock skyrocketed 40% on the news. Meanwhile, Novo Nordisk's stock was hit, sliding 4%, and Eli Lilly's stock was down ...
Gyre: Intriguing Upcoming Data Catalyst, But I'm Still On Sidelines
Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...
Hims & Hers offers upbeat forecast, but stock slides after hours
Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading, in an echo of ...
Le Lézard2d
Domo Agent Catalyst Delivers Intelligent AI Agents, Enabling Fully Independent Business Processes
Domo today announced Agent Catalyst, the newest addition to Domo AI, the company's award-winning lineup of cutting-edge AI solutions and tools. Built on top of Domo AI's secure and private platform, ...
Monte Rosa Therapeutics, Inc. (GLUE) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET. Company Participants. Andrew Funderburk - Senior Vice President, Investor Re ...